Citations 1
Intergroup randomized phase III study of postoperative oxaliplatin, 5-fluorouracil and leucovorin (mFOLFOX6) vs mFOLFOX6 and bevacizumab (Bev) for patients (pts) with stage II/ III rectal cancer receiving pre-operative chemoradiation.
Benson, Al B. , Meropol, Neal J. , Catalano, Paul J. , Chakravarthy, Bapsi, Flynn, Patrick J. , Catalano, Robert B., Giantonio, Bruce J. , Mitchell, Edith P. , Haller, Daniel G. , Leichman, Cynthia G., Petrelli, Nicholas J. , Tepper, Joel E. , Brierley, James D. , Sigurdson, Elin R., Whittington, Richard M., O’Dwyer, Peter J. , Chakravarthy, A. Bapsi , Zhao, Fengmin , Sinicrope, Frank A. , Whittington, Richard M.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3616-3616
